We are live on ! Find out more
BSX icon

Boston Scientific

888 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 290 increasing their positions, 322 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 95

1% more funds holding

Funds holding: 877888 (+11)

3% less capital invested

Capital invested by funds: $56.3B → $54.6B (-$1.66B)

10% less repeat investments, than reductions

Existing positions increased: 290 | Existing positions reduced: 322

1.09% less ownership

Funds ownership: 91.5%90.41% (-1.1%)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

42% less call options, than puts

Call options by funds: $271M | Put options by funds: $467M

Holders
888
Holders Change
+11
Holders Change %
+1.25%
% of All Funds
13.67%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
121
Increased
290
Reduced
322
Closed
95
Calls
$271M
Puts
$467M
Net Calls
-$196M
Net Calls Change
-$17.7M
Name Holding Trade Value Shares
Change
Change in
Stake
RC
376
RegentAtlantic Capital
New Jersey
$1.7M +$330K +7,847 +24%
MWM
377
Midwest Wealth Management
Indiana
$1.7M +$127K +3,025 +8%
Verition Fund Management
378
Verition Fund Management
Connecticut
$1.65M +$1.63M +38,779 New
KRSITF
379
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$1.65M +$81.9K +1,950 +5%
BF
380
BOK Financial
Oklahoma
$1.63M -$276K -6,573 -15%
YC
381
Yarbrough Capital
Tennessee
$1.63M +$1.62M +38,456 New
BPCE
382
Bank Pictet & Cie (Europe)
Germany
$1.63M -$3.24M -77,100 -67%
VPIM
383
Vanguard Personalized Indexing Management
California
$1.63M +$52.6K +1,251 +3%
ECM
384
Everence Capital Management
Indiana
$1.62M
MML Investors Services
385
MML Investors Services
Massachusetts
$1.56M +$95.1K +2,264 +7%
FCM
386
Fairbanks Capital Management
California
$1.54M +$2.44K +58 +0.2%
AP
387
Advisor Partners
California
$1.53M -$31.1K -740 -2%
NSEDCP
388
NJ State Employees Deferred Compensation Plan
New Jersey
$1.53M
MC
389
Moors & Cabot
Massachusetts
$1.52M +$54.6K +1,300 +4%
DHFB
390
Dixon Hubard Feinour & Brown
Virginia
$1.51M +$1.5M +35,660 New
FB
391
Fulton Bank
Pennsylvania
$1.51M -$59.2K -1,408 -4%
RIM
392
Redpoint Investment Management
Australia
$1.51M
ACM
393
AlphaCrest Capital Management
New York
$1.51M +$187K +4,448 +14%
Wealthfront Advisers
394
Wealthfront Advisers
California
$1.5M -$6.05K -144 -0.4%
CSS
395
Cubist Systematic Strategies
Connecticut
$1.5M -$779K -18,546 -34%
FCA
396
FinTrust Capital Advisors
South Carolina
$1.5M -$36.8K -875 -2%
OF
397
Outfitter Financial
Maine
$1.47M -$1.05K -25 -0.1%
JG
398
Jefferies Group
New York
$1.47M -$929K -22,119 -39%
AII
399
AGF Investments Inc
Ontario, Canada
$1.42M +$45.7K +1,088 +3%
CP
400
Cumberland Partners
Ontario, Canada
$1.42M +$63K +1,500 +5%

BSX Hedge Fund Activity: Q4 2021 in Review

888 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2021, worth a combined $54.6B — down 3% from $56.3B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new BSX positions and 95 closed out — a net gain of 26 holders — while 290 added to existing stakes and 322 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $508M. The largest seller was Wellington Management Group, cutting an estimated $391M.

  • 888 institutional investors held Boston Scientific (BSX) as of Q4 2021, up from 877 in Q3 2021.
  • Funds reported $54.6B of Boston Scientific stock for Q4 2021, down 3% quarter-over-quarter.
  • 121 funds opened new Boston Scientific positions in Q4 2021 and 95 closed out, a net change of +26 holders.
  • The largest Boston Scientific buyer in Q4 2021 was Viking Global Investors, an estimated $508M added.
  • The largest Boston Scientific seller in Q4 2021 was Wellington Management Group, an estimated $391M sold.

Based on aggregated 13F filings for Q4 2021.